ProCE Banner Events


PCE Winter Oncology Conference

PCE, the national leader in continuing education for NPs and PAs, returns in January with our virtual Winter Oncology Conference. This complimentary CE/CME meeting is tailored to meet the clinical needs and evolving scope of practice of NPs, PAs, and nurses who practice in oncology. Live streamed for your convenience and to allow access nationwide. Register now!

Physician Assistants/Physician Associates: 6.00 AAPA Category 1 CME credits

Nurse Practitioners: 6.00 Nursing contact hours, includes 6.00 hours of pharmacotherapy credit.

This event has expired. No longer available for credits.

Credits Available

6.00 ANCC | AAPA

Who Should Attend

Oncology NPs, PAs, and RNs

Time and location

Saturday, January 28, 2023

10:00 AM - 4:05 PM Eastern Time (ET)


Rasheda Persinger, MSN, AGNP-C, AOCNP

Medical Oncology Lead Nurse Practitioner
Sidney Kimmel Cancer Center Sibley Memorial Hospital
Johns Hopkins System
Washington, DC

Mary Weinstein Dunn, MSN

Nurse Practitioner
Department of Urology and Medicine, Division of Oncology
University of North Carolina Chapel Hill
Chapel Hill, North Carolina

Laura M. Spring, MD

Breast Medical Oncologist
Mass General Cancer Center
Harvard Medical School
Boston, Massachusetts

Sarah Traverso, MMS, PA-C

Physician Assistant
Division of Genitourinary Oncology
Northwestern Medicine
Chicago, Illinois

Sara Tinsley-Vance, PhD, MSN, APRN-BC, AOCN

Nurse Practitioner and Researcher
Malignant Hematology
Moffitt Cancer Center
Tampa, Florida

Beth Sandy, MSN, CRNP

Nurse Practitioner
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania

Patient Susan Poteat,

Patient Denise Cutlip,

Jennifer Bridgeforth-Jackson,

Adjunct Professor
School of Business
National Louis University
Chicago, Illinois


9:30 AM – 10:00 AM ET     Log-in 

10:00 AM - 10:05 AM ET    Welcome and Opening Remarks

10:05 AM – 11:05 AM ET     Challenges in Myelodysplastic Syndromes (MDS): Risk Stratification and Integrating Novel Treatment Approaches
Sara M.Tinsley-Vance, NP

11:05 AM - 12:05 PM ET         Improving the Odds in Metastatic Castration-Sensitive Prostate Cancer
Sarah Traverso, PA-C

12:05 PM - 1:05 PM ET         Keeping Up With the Rapid Emergence of Strategies for Advanced Renal Cell Carcinoma
Mary W. Dunn, MSN, RN, OCN, NP-C

1:05 PM - 2:05 PM ET          Patient and Provider: What Can We Learn From Each Other?
Denise Cutlip, Susan Poteat, Beth Sandy, NP, Sarah Traverso, PA-C, Jennifer Bridgeforth-Jackson

2:05 PM - 3:05 PM ET         Biomarker Testing in NSCLC: Who, What, When?
Rasheda Persinger, MSN

3:05 PM  - 4:05 PM ET      Introducing Novel Agents Into the Armamentarium for Triple-Negative Breast Cancer
Laura Spring, MD

4:05 PM ET                           Summary and Closing Remarks


Joint Accreditation Statement

In support of improving patient care, Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

ANCC Credit Designation

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 6.0 contact hours.

AAPA Credit Designation

Partners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

IPCE Credit Designation


This activity was planned by and for the healthcare team, and learners will receive 6.0 Interprofessional Continuing Education (IPCE) credit for learning and change.

Disclosure of Conflicts of Interest 
Partners for Advancing Clinical Education (PACE) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.


Provided by Partners for Advancing Clinical Education (PACE), in partnership with Smart Patients.

This program is supported by educational grants from Amgen, Bayer HealthCare Pharmaceuticals Inc , Exelixis, Inc., Gilead Sciences, Inc., and Karyopharm Therapeutics Inc.